Related Experiment Video
Updated: Feb 4, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Emerging drugs for focal epilepsy
Marco Mula1,2
1a Institute of Medical and Biomedical Education , St George's University of London , London , UK.
New epilepsy treatments are in development, with some drugs like Everolimus showing promise as precision medicine. Further research is needed to assess the long-term safety and efficacy of these novel antiepileptic drugs (AEDs).
Area of Science:
- Neurology
- Pharmacology
Background:
- Epilepsy affects 50 million globally, with one-third of patients experiencing uncontrolled seizures despite existing antiepileptic drugs (AEDs).
- Current AEDs are insufficient for a significant patient population, necessitating the development of novel therapeutic agents.
Purpose of the Study:
- To review compounds in preclinical and clinical development for focal epilepsies.
- To identify new molecular targets for epilepsy treatment.
Main Methods:
- Literature review of current research on epilepsy treatments.
- Analysis of compounds in various stages of drug development (preclinical, Phase II, Phase III).
Main Results:
- Several compounds including Everolimus, Ganaxolone, Cannabidavirin, Padsevonil, and Selurampanel show promise for focal epilepsy treatment.
- Everolimus is highlighted as a precision medicine and disease-modifying agent, though long-term safety data is pending.
- Cannabidavirin, Padsevonil, and Selurampanel represent potential fourth-generation AEDs if they progress successfully.
Conclusions:
- Novel therapeutic agents are emerging for focal epilepsies, offering hope for patients with uncontrolled seizures.
- Further evaluation of long-term safety, tolerability, cognitive effects, and drug interactions is crucial for the success of these new antiepileptic drugs (AEDs).
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Intracellular Signaling Affects Focal Adhesions
Some...
Applications of GIS: Disaster Management and Emergency Response
Pharmacokinetics: Drug–Drug Interactions

